Evaluation of the Consequences of Poly Vaccination on Innate Immunity : Applications to a Military Population
NCT ID: NCT06110741
Last Updated: 2023-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
410 participants
OBSERVATIONAL
2023-11-30
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Analysis of monocyte immune training induced by vaccination will provide a better understanding of the indirect effects of vaccination and their persistence over time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits
NCT02079701
A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age
NCT03313050
A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine
NCT00955851
Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose
NCT01119625
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
NCT06271681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sampling and survey group
This group will complete questionnaires and participate in sample collection.
Blood and saliva sampling
Collecting blood and saliva sample
Survey
Collecting data on infectious diseases during the study period
Survey group
This group will only complete questionnaires
Survey
Collecting data on infectious diseases during the study period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood and saliva sampling
Collecting blood and saliva sample
Survey
Collecting data on infectious diseases during the study period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>18yo
* overseas deployment scheduled between 30 and 60 days after vaccination session
* adult
* able to give consent
Exclusion Criteria
* having received a live vaccine within 6 months prior to inclusion
* having received an attenuated vaccine within 3 months prior to inclusion
* pregnancy or breastfeeding
* vaccine contraindication
* major incapacity
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01356-39
Identifier Type: OTHER
Identifier Source: secondary_id
2023PPRC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.